Table II.
Categories
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Agreement (%)
|
S, I, R
|
S, (I + R)a |
(S + I), Rb |
|||||||||
Antimicrobial | A | Ba | Cb | Weighted kappa | Kappa | PI | BI | PABAK | Kappa | PI | BI | PABAK |
Ciprofloxacin | 96 | 96 | 97 | 0.45 | 0.36 | 0.93 | 0.04 | 0.92 | 0.49 | 0.95 | 0.03 | 0.95 |
Azithromycin | 73 | 73 | 73 | 0.25 | 0.25 | 0.59 | 0.27 | 0.46 | 0.25 | 0.59 | 0.27 | 0.46 |
Clindamycin | 73 | 81 | 83 | 0.50 | 0.18 | 0.75 | 0.19 | 0.62 | 0.57 | 0.45 | 0.14 | 0.67 |
Erythromycin | 78 | 91 | 85 | 0.58 | 0.13 | 0.89 | 0.09 | 0.82 | 0.62 | 0.49 | 0.13 | 0.71 |
Nalidixic Acid | 15 | 18 | 82 | 0.15 | 0.02 | 0.07 | 0.82 | −0.62 | 0.34 | 0.70 | 0.14 | 0.65 |
Ampicillin | 27 | 33 | 79 | 0.22 | 0.05 | 0.03 | 0.67 | −0.34 | 0.35 | 0.66 | 0.17 | 0.58 |
Chloramphenicol | 75 | 75 | 97 | 0.17 | 0.03 | 0.64 | 0.25 | 0.5 | −0.007 | 0.97 | 0.02 | 0.95 |
Gentamicin | 99 | 99 | ~100 | 0.00 | 0.00 | 0.99 | 0.00 | 0.98 | 0.00 | 0.99 | 0.00 | 0.99 |
Streptomycin | 84 | 86 | 85 | 0.68 | 0.66 | 0.41 | 0.14 | 0.72 | 0.66 | 0.37 | 0.09 | 0.71 |
Tetracycline | 76 | 84 | 79 | 0.66 | 0.67 | 0.25 | 0.16 | 0.68 | 0.58 | 0.12 | 0.20 | 0.57 |
Intermediate isolates were categorized as resistant.
Intermediate isolates were classified as susceptible.
A — susceptible, intermediate and resistant categories; PI — preference index; BI — bias index; PABAK — prevalence-adjusted bias-adjusted kappa.